GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Interpharm Holdings Inc (GREY:IPAH) » Definitions » Debt-to-Revenue

Interpharm Holdings (Interpharm Holdings) Debt-to-Revenue : 0.59 (As of Dec. 2007)


View and export this data going back to 2008. Start your Free Trial

What is Interpharm Holdings Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Interpharm Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2007 was $30.68 Mil. Interpharm Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2007 was $7.79 Mil. Interpharm Holdings's annualized Revenue for the quarter that ended in Dec. 2007 was $64.86 Mil. Interpharm Holdings's annualized Debt-to-Revenue for the quarter that ended in Dec. 2007 was 0.59.


Interpharm Holdings Debt-to-Revenue Historical Data

The historical data trend for Interpharm Holdings's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Interpharm Holdings Debt-to-Revenue Chart

Interpharm Holdings Annual Data
Trend Jun98 Jun99 Jun00 Jun01 Jun02 Jun03 Jun04 Jun05 Jun06 Jun07
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only N/A 0.19 0.43 0.25 0.35

Interpharm Holdings Quarterly Data
Mar03 Jun03 Sep03 Dec03 Mar04 Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.22 0.21 0.43 0.45 0.59

Competitive Comparison of Interpharm Holdings's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Interpharm Holdings's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Interpharm Holdings's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Interpharm Holdings's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Interpharm Holdings's Debt-to-Revenue falls into.



Interpharm Holdings Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Interpharm Holdings's Debt-to-Revenue for the fiscal year that ended in Jun. 2007 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(12.057 + 14.488) / 75.587
=0.35

Interpharm Holdings's annualized Debt-to-Revenue for the quarter that ended in Dec. 2007 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(30.681 + 7.79) / 64.856
=0.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Dec. 2007) Revenue data.


Interpharm Holdings Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Interpharm Holdings's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Interpharm Holdings (Interpharm Holdings) Business Description

Traded in Other Exchanges
N/A
Address
75 Adams Avenue, Hauppague, NY, USA, 11788
Website
Interpharm Holdings Inc manufactures generic and over-the-counter medications. The company also pursues the development of other generic drugs in broad categories.

Interpharm Holdings (Interpharm Holdings) Headlines

No Headlines